Definite diagnosis of ductal carcinoma in situ of the breast or lobular carcinoma in situ of the breast.
The diagnosis of ductal carcinoma in situ of the breast or lobular carcinoma in situ of the breast must be supported by a histolopathological biopsy report and made by a specialist.
Exclusion
- No benefit will be payable under the definition of "ductal carcinoma in situ of the breast or lobular carcinoma in situ of the breast" if:
Within the first
90 days following the later of, the effective date of this coverage, or the date of last reinstatement of this coverage, the insured person has any of the following:
- signs, symptoms or investigations, that lead to a diagnosis of cancer (covered or excluded under this coverage), regardless of when the diagnosis is made; or
- a diagnosis of cancer (covered or excluded under this coverage).
Obligation to inform the Company
Medical information about the diagnosis and any signs, symptoms or investigations leading to the diagnosis must be reported to the Company within 6 months of the date of the diagnosis.
If this information is not provided within this period, the Company has the right to deny any claim for cancer or any covered condition caused by any cancer or its treatment.
